CU24112B1 - Antígenos vacunales quiméricos contra el virus de la hepatitis c - Google Patents

Antígenos vacunales quiméricos contra el virus de la hepatitis c

Info

Publication number
CU24112B1
CU24112B1 CU20120153A CU20120153A CU24112B1 CU 24112 B1 CU24112 B1 CU 24112B1 CU 20120153 A CU20120153 A CU 20120153A CU 20120153 A CU20120153 A CU 20120153A CU 24112 B1 CU24112 B1 CU 24112B1
Authority
CU
Cuba
Prior art keywords
virus
chemical
against hepatitis
antigens against
vaccinal antigens
Prior art date
Application number
CU20120153A
Other languages
English (en)
Other versions
CU20120153A7 (es
Inventor
Carrera Santiago Dueñas
Noriega Daylen Aguilar
Cañizares Yalena Amador
Ponce De León Liz Álvarez-Lajonchere
Donato Gillian Martínez
Blanco Sonia González
Original Assignee
Ct De Ingeniería Genética Y Biotecnología
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Ingeniería Genética Y Biotecnología filed Critical Ct De Ingeniería Genética Y Biotecnología
Priority to CU20120153A priority Critical patent/CU24112B1/es
Priority to IN3925DEN2015 priority patent/IN2015DN03925A/en
Priority to CN201380064380.9A priority patent/CN104837498B/zh
Priority to RU2015121429A priority patent/RU2639504C2/ru
Priority to EP13801461.8A priority patent/EP2915544B1/en
Priority to JP2015540044A priority patent/JP6259831B2/ja
Priority to ES13801461.8T priority patent/ES2644801T3/es
Priority to MX2015005651A priority patent/MX358507B/es
Priority to US14/440,443 priority patent/US9676825B2/en
Priority to AU2013339846A priority patent/AU2013339846B2/en
Priority to CA2901346A priority patent/CA2901346C/en
Priority to KR1020157012656A priority patent/KR102093495B1/ko
Priority to PCT/CU2013/000006 priority patent/WO2014067498A1/es
Priority to ARP130104019A priority patent/AR093341A1/es
Publication of CU20120153A7 publication Critical patent/CU20120153A7/es
Priority to ZA2015/03036A priority patent/ZA201503036B/en
Publication of CU24112B1 publication Critical patent/CU24112B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24271—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CU20120153A 2012-11-05 2012-11-05 Antígenos vacunales quiméricos contra el virus de la hepatitis c CU24112B1 (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CU20120153A CU24112B1 (es) 2012-11-05 2012-11-05 Antígenos vacunales quiméricos contra el virus de la hepatitis c
MX2015005651A MX358507B (es) 2012-11-05 2013-10-28 Antigenos vacunales quimericos contra el virus de la hepatitis c.
US14/440,443 US9676825B2 (en) 2012-11-05 2013-10-28 Chimeric vaccine antigens against hepatitis C virus
RU2015121429A RU2639504C2 (ru) 2012-11-05 2013-10-28 Химерные антигены для вакцины против вируса гепатита с
EP13801461.8A EP2915544B1 (en) 2012-11-05 2013-10-28 Chimeric vaccine antigens against hepatitis c virus
JP2015540044A JP6259831B2 (ja) 2012-11-05 2013-10-28 Ｃ型肝炎ウイルスに対するキメラワクチン抗原
ES13801461.8T ES2644801T3 (es) 2012-11-05 2013-10-28 Antígenos de vacuna quimérica contra el virus de la hepatitis c
IN3925DEN2015 IN2015DN03925A (es) 2012-11-05 2013-10-28
CN201380064380.9A CN104837498B (zh) 2012-11-05 2013-10-28 针对丙型肝炎病毒的嵌合疫苗抗原
AU2013339846A AU2013339846B2 (en) 2012-11-05 2013-10-28 Chimeric vaccine antigens against hepatitis C virus
CA2901346A CA2901346C (en) 2012-11-05 2013-10-28 Chimeric vaccine antigens against hepatitis c virus
KR1020157012656A KR102093495B1 (ko) 2012-11-05 2013-10-28 C형 간염 바이러스에 대한 키메라 백신 항원
PCT/CU2013/000006 WO2014067498A1 (es) 2012-11-05 2013-10-28 Antígenos vacunales quiméricos contra el virus de la hepatitis c
ARP130104019A AR093341A1 (es) 2012-11-05 2013-11-04 Antigenos vacunales quimericos contra el virus de la hepatitis c
ZA2015/03036A ZA201503036B (en) 2012-11-05 2015-05-04 Chimeric vaccine antigens against hepatitis c virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20120153A CU24112B1 (es) 2012-11-05 2012-11-05 Antígenos vacunales quiméricos contra el virus de la hepatitis c

Publications (2)

Publication Number Publication Date
CU20120153A7 CU20120153A7 (es) 2014-06-27
CU24112B1 true CU24112B1 (es) 2015-08-27

Family

ID=49724426

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20120153A CU24112B1 (es) 2012-11-05 2012-11-05 Antígenos vacunales quiméricos contra el virus de la hepatitis c

Country Status (15)

Country Link
US (1) US9676825B2 (es)
EP (1) EP2915544B1 (es)
JP (1) JP6259831B2 (es)
KR (1) KR102093495B1 (es)
CN (1) CN104837498B (es)
AR (1) AR093341A1 (es)
AU (1) AU2013339846B2 (es)
CA (1) CA2901346C (es)
CU (1) CU24112B1 (es)
ES (1) ES2644801T3 (es)
IN (1) IN2015DN03925A (es)
MX (1) MX358507B (es)
RU (1) RU2639504C2 (es)
WO (1) WO2014067498A1 (es)
ZA (1) ZA201503036B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3319997B1 (en) 2015-07-07 2025-05-07 The Governors of the University of Alberta Hepatitis c virus immunogenic compositions and methods of use thereof
CN109963587A (zh) * 2016-09-21 2019-07-02 艾伯塔大学理事会 丙型肝炎病毒免疫原性组合物及其使用方法
US11596679B2 (en) 2017-04-27 2023-03-07 Vanderbilt University Hepatitis C virus gene sequences and methods of use therefor
WO2019173925A1 (en) 2018-03-16 2019-09-19 The Governors Of The University Of Alberta Hepatitis c virus peptide compositions and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ520976A (en) 1999-11-19 2005-01-28 Csl Ltd Vaccine compositions
US6544780B1 (en) * 2000-06-02 2003-04-08 Genphar, Inc. Adenovirus vector with multiple expression cassettes
CU23496A1 (es) 2004-09-03 2010-02-23 Ct Ingenieria Genetica Biotech Composición vacunal contra el virus de la hepatitis c
JP5405832B2 (ja) * 2006-01-04 2014-02-05 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Ｈｃｖ特異的なｔ細胞の活性化
US7256008B2 (en) 2006-01-06 2007-08-14 Abbott Laboratories Determination of concentration of FK778 by competitive immunoassay
US20110110974A1 (en) * 2007-10-29 2011-05-12 Erik Depla Methods and kits for inducing a ctl response using a prime boost regimen
CA2722043A1 (en) * 2008-04-25 2009-10-29 Toray Industries, Inc. Nucleic acid comprising chimeric gene derived from hepatitis c virus
EP2331125A4 (en) * 2008-09-19 2013-03-27 Globeimmune Inc IMMUNOTHERAPY FOR CHRONIC HEPATITIS C-VIRUS INFECTIONS
WO2010047830A2 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute Agents for hcv treatment

Also Published As

Publication number Publication date
IN2015DN03925A (es) 2015-10-02
JP6259831B2 (ja) 2018-01-10
MX2015005651A (es) 2015-08-20
AU2013339846B2 (en) 2017-08-17
CN104837498B (zh) 2018-05-18
RU2015121429A (ru) 2016-12-27
WO2014067498A1 (es) 2014-05-08
CU20120153A7 (es) 2014-06-27
AR093341A1 (es) 2015-06-03
EP2915544A1 (en) 2015-09-09
CN104837498A (zh) 2015-08-12
KR102093495B1 (ko) 2020-03-26
CA2901346A1 (en) 2014-05-08
EP2915544B1 (en) 2017-08-09
KR20150079694A (ko) 2015-07-08
US9676825B2 (en) 2017-06-13
ZA201503036B (en) 2016-01-27
JP2015536936A (ja) 2015-12-24
US20150307558A1 (en) 2015-10-29
RU2639504C2 (ru) 2017-12-21
AU2013339846A1 (en) 2015-05-14
MX358507B (es) 2018-08-22
ES2644801T3 (es) 2017-11-30
CA2901346C (en) 2019-04-23

Similar Documents

Publication Publication Date Title
IL262123A (en) Influenza virus vaccines and uses thereof
IL252446A0 (en) Inhibitors of hepatitis c virus
IL238320B (en) Broadly-neutralizing anti-hiv antibodies
IL232780A0 (en) Influenza virus vaccines and uses thereof
CO6811814A2 (es) Vacuna de virus dengue inactivado
SG11201509985XA (en) Influenza virus reassortment
DK3447131T3 (da) Influenza a-virusmutanter
EP2663334A4 (en) ANTIBODIES AGAINST INFLUENZA
BR112014033077A2 (pt) combinação de vacina.
IL227789A0 (en) Hepatitis c virus inhibitors
CO6821947A2 (es) Inhibidores del virus de la hepatitis c
CO6940424A2 (es) Inhibidores del virus de la hepatitis c
PL2935313T3 (pl) Szczepionki przeciwko wirusowi zapalenia wątroby typu b
PT2806891T (pt) Vacinas baseadas no vírus parainfluenza 5
HRP20181874T1 (hr) Anti-cxcr3 protutijela
IL240936A0 (en) Redifferentiation of influenza b virus
EP2876161A4 (en) VACCINE
CO6821952A2 (es) Inihibidores del virus de la hepatitis c
EP2974740A4 (en) HEPATITIS B VACCINE
BR112014005756A2 (pt) vacina
ZA201503458B (en) Hepatitis c virus inhibitors
EP2828284A4 (en) JCV NEUTRALIZING ANTIBODIES
IL240025A0 (en) Influenza virus redifferentiation
EP2763699A4 (en) VACCINE
CU24112B1 (es) Antígenos vacunales quiméricos contra el virus de la hepatitis c

Legal Events

Date Code Title Description
FG Grant of patent